在整个转移级联中,免疫逃避机制的复杂性
Nicole M Haynes1,2, Thomas B Chadwick1,2, Belinda S Parker3,4
1Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Nature immunology
|September 16, 2024
概括
癌症转移包括免疫逃脱. 本综述详细介绍了瘤细胞如何适应和与免疫系统相互作用以传播,强调需要多方面的策略来克服免疫抑制和管理转移性疾病.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 转移,癌症的扩散,仍然是一个重要的临床挑战.
- 免疫逃生机制对于瘤细胞在转移期间的生存和传播至关重要.
- 了解瘤细胞可塑性和免疫相互作用对于有效的癌症治疗至关重要.
研究的目的:
- 探索整个转移级联的免疫逃生机制.
- 为了分析扩散瘤细胞的适应性可塑性.
- 阐明免疫系统在培养免疫抑制瘤微环境中的作用.
主要方法:
- 关于癌症转移和免疫学的当前文献的综述.
- 在扩散的上皮瘤细胞中分析适应性可塑性.
- 检查瘤细胞微环境相互作用和免疫系统影响.
主要成果:
- 散布的瘤细胞表现出适应性可塑性,经历表型转变以生存.
- 天生的和适应性免疫系统都会导致免疫抑制环境,促进转移.
- 免疫逃生机制是瘤细胞扩散和有机化的组成部分.
结论:
- 管理转移性疾病需要向抑制抗瘤免疫力的机制.
- 对瘤-免疫相互作用的全面理解对于开发新的治疗策略至关重要.
- 本综述提供了对转移性进展和免疫规避的复杂相互作用的见解.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


